Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN)

CUSIP: 92790C104

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock, $0.01 par value per share
Shares outstanding
102,220,000
Total 13F shares
5,057,213
Share change
+4,828,213
Total reported value
$84,503,000
Price per share
$16.71
Number of holders
28
Value change
+$80,676,000
Number of buys
26

Quarterly Holders Quick Answers

What is CUSIP 92790C104?
CUSIP 92790C104 identifies VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Atlas Venture Advisors, Inc.
13F
Company
0.2%
209,505
 $3,446,000 — 31 Dec 2020
13F
VR Adviser, LLC
13F
Company
0.02%
19,495
 $321,000 — 31 Dec 2020
13F

Institutional Holders of Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN) as of Q1 2021

As of 31 Mar 2021, Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,057,213 shares. The largest 10 holders included Ally Bridge Group (NY) LLC, WELLINGTON MANAGEMENT GROUP LLP, Logos Global Management LP, BVF INC/IL, Cormorant Asset Management, LP, Point72 Asset Management, L.P., RA CAPITAL MANAGEMENT, L.P., Ghost Tree Capital, LLC, Atlas Venture Advisors, Inc., and D. E. Shaw & Co., Inc.. This page lists 28 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
2
Q1 2021 holders
28
Holder diff
26
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 Value $ Q1 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .